Beijing Qingke Biotechnology

Beijing Qingke Biotechnology

A gene synthesis platform enterprise with an independent whole industry chain.

Launch date
Employees
Market cap
-
Enterprise valuation
€200—300m (Dealroom.co estimates Dec 2022.)
Beijing China (HQ)
Authorizing premium user...